TOP STORIES
First-in-Human Study for New Application of Photodynamic Therapy with 5-Aminolevulinic Acid for Extracorporeal Photopheresis for ExtracorporealPhotopheresis Published in “Pharmaceutics” conference
2022-02-15 08:41:00
Ascelia Pharma AB (publ) (ticker: ACE) today announced that the study where Orviglance® was compared against a gadolinium-based contrast agent has been accepted as an oral scientific presentation at t …